危重病人監護人員的耗損綜合症

...量分析認爲4種因素與嚴重BOS相關：個人特徵(年齡,OR1.03/y;CI[1.01-1.04];P=0.0008))、組織因素(能夠休假(OR,0.69;CI[0.52-0.91];P=0.009)，加入ICU研究團體(OR,0.74;CI[0.56-0.97];P=0.03))、與護士長(OR,0.92/point;CI[0.86-0.98];P=0.02)或醫生(OR,0.81;CI[0.74-0.87];P=0....

Helicobacterpylori,Pepsinogen,andGastricAdenocarcinomainHawaii

...nterofHawaii,UniversityofHawaii,Honolulu,DepartmentofPathology,UniversityofCincinnatiMedicalCenter,Cincinnati,OhioDepartmentofMedicine,NewYorkUniversitySchoolofMedicine,NewYorkDepartmentofInternalMedicine,FacultyofMedicine,TohoUniversitySchoolofMedicine,Tokyo,JapanBackground.Theobjectivewastoinvesti...

RiskfactorsforagerelatedcataractinaruralpopulationofsouthernIndia:theAravindComprehensiveEyeStudy

...SA3DanaCenterforPreventiveOphthalmology,JohnsHopkinsUniversitySchoolsofMedicineandPublicHealth,Baltimore,MD,USAABSTRACTAim:TodetermineriskfactorsforlensopacitiesandagerelatedcataractinanolderruralpopulationofsouthernIndia.Methods:Acrosssectionalpopulationbasedstudyof5150peopleaged40yearsandabovefrom...

VitaminA,retinol,andcarotenoidsandtheriskofgastriccancer:aprospectivecohortstudy

...heDivisionofNutritionalEpidemiology,TheNationalInstituteofEnvironmentalMedicine,KarolinskaInstitute,Stockholm,Sweden(SCLandAW);theDepartmentofSurgeryandCentreforClinicalResearch,CentralHospital,Västerås,Sweden(LB);theDepartmentofSurgery,ÖrebroUniversityHospital,Örebro,Sweden(IN)...

Gemcitabine爲基礎的聯合治療與gemcitabine單獨治療不能手術的胰腺癌的療效比較

...007年01月10日WorldJGastroenterol.2006Nov21;12(43):6973-81.29爲比較Gemcitabine爲基礎的聯合治療與gemcitabine(GEM)單獨治療晚期胰腺癌(APCa)的療效，研究人員檢索了MEDLINE和EMBASE數據庫，選擇了GEM爲基礎的聯合治療與GEM單獨治療APCa的隨機對照臨牀...

Dietaryfatintakeandriskofcoronaryheartdisease:theStrongHeartStudy

...ee1FromtheCenterforAmericanIndianHealthResearch,UniversityofOklahomaHealthSciencesCenter,OklahomaCity,OK(JXandETL);MedstarResearchInstitute,Hyattsville,MD(SE-A,BVH,andCM);theNationalHeart,Lung,andBloodInstitute,NationalInstitutesofHealth,Bethesda,MD(CLandRRF);theIndianHealthService,AberdeenAreaOffic...

ICU患者病死率危險因素的前瞻性臨牀研究

...(35.9%)發生醫院感染。獨立危險因素有平均年齡(HR1.08，95%CI0.98～1.15)、APACHEII評分(HR2.01，95%CI1.62～2.87)、機械通氣(HR1.87，95%CI1.38～2.92)、醫院感染(HR0.41，95%CI0.31～0.68)、鼻飼(HR0.51，95%CI0.32～0.69)、ICU住院天數(HR,0.45;95%CI,0.24～0.60)、...

補充鈣劑和維生素D對接受抗病毒治療的HIV患兒骨密度的影響

...線時，治療組的腰椎T值要明顯低於對照組（前者-2.3，95%CI：-4.3~-1.1；後者-0.9，95%CI：-1.7~0.3）；治療組的骨密度也較對照組低（前者0.6g/cm2,95%CI：0.3~0.8；後者0.7g/cm2,95%CI：0.5~1.0）。治療26個月後，治療組的腰椎T值上升至-1.5(95%CI,-...

T1-T2乳腺癌患者保乳手術和輔助治療後存活率和復發情況

...見，Cox迴歸模型逐步選入變量顯示一些參數如化療(HR1.53;CI1.19-1.95)、pT狀態(HR1.62,CI1.31-2.01)、腋窩淋巴結陽性(HR1.92,CI1.66-2.22)以及局部復發(HR4.58;CI3.66-5.73)成爲乳腺癌死亡的獨立預測因素。此外，研究人員發現1991年前治療的患者與1...

帶器妊娠對妊娠結局的不良影響

...IUD留置組自然流產率明顯高於取出IUD組(54%：20%;RR，2.7;95%CI，1.8~3.9)。對有報道113例自然流產病例中，有29例(26%)發生在妊娠第2~3個月(妊娠中期)。其中，僅有3例取出IUD。儘管沒有統計學意義，但是IUD留置宮腔組的早產率高於IUD取...